Skip to main content

Bridgefront Capital, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1725690 AUSTIN, TX

Position in BCRX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$389,263
+$209,760 QoQ
Shares Held
40,889
+72.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bridgefront Capital, LLC holds $2,674,930 across 3 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $389,263 40,889
2025-09-30 $179,503 23,650
2025-06-30 $385,091 42,979
2024-09-30 $251,757 33,126
2024-06-30 $79,808 12,914
2023-09-30 $115,566 16,323
2023-06-30 $142,926 20,302
2021-03-31 $203,684 20,028